In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...

But for diabetes and obesity drugs like Ozempic and Zepbound, known as GLP-1s, cheaper copycats emerged almost ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...

The first new guidelines in 10 years from the American Stroke Association for people and doctors reflect a better ...

A pregnant woman has been told to 'reconsider' her choice of name for her baby boy, as people have warned it's 'cruel' and ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...